{
    "caseSensitive": true,
    "concept": [
        {
            "code": "01",
            "definition": "Is the patient currently being treated in the intensive care unit?",
            "display": "Is the patient in the intensive care unit?"
        },
        {
            "code": "02",
            "definition": "Confirmed Covid-19 diagnosis as main reason for enrolment in the study",
            "display": "Study inclusion due to Covid-19"
        },
        {
            "code": "03",
            "definition": "Has the patient participated in one or more interventional clinical trials?",
            "display": "Participation in interventional clinical trials"
        },
        {
            "code": "04",
            "definition": "EudraCT (European Union Drug Regulating Authorities Clinical Trials) registration number",
            "display": "EudraCT Number‎"
        },
        {
            "code": "05",
            "definition": "A unique identification code given to each clinical study registered on ClinicalTrials.gov.",
            "display": "NCT number"
        },
        {
            "code": "06",
            "definition": "Sepsis-related organ failure assessment score",
            "display": "SOFA-Score"
        },
        {
            "code": "antipyretic",
            "definition": "Pharmaceutical product containing a substance that reduces fever",
            "display": "Product containing antipyretic"
        },
        {
            "code": "camostat",
            "definition": "Pharmaceutical product containing the substance camostat",
            "display": "Product containing camostat"
        },
        {
            "code": "favipiravir",
            "definition": "Pharmaceutical product containing the substance favipiravir",
            "display": "Product containing favipiravir"
        },
        {
            "code": "convalescent-plasma",
            "definition": "Convalescent plasma from patients who have recovered from COVID-19",
            "display": "Convalescent plasma"
        },
        {
            "code": "steroids-gt",
            "definition": "A dose of steroids that is greater than an equivalent dose of prednisone of 0.5 mg/kg",
            "display": "Steroids (> 0.5 mg/kg prednisone equivalents)"
        },
        {
            "code": "steroids-lt",
            "definition": "A dose of steroids that is equal or less than an equivalent dose of prednisone of 0.5 mg/kg",
            "display": "Steroids (<= 0.5 mg/kg prednisone equivalents)"
        }
    ],
    "contact": [
        {
            "telecom": [
                {
                    "system": "url",
                    "value": "https://www.bihealth.org/en/research/core-facilities/interoperability/"
                }
            ]
        }
    ],
    "content": "complete",
    "date": "2020-10-29",
    "description": "Codes for GECCO eCRF parameters where no code from standard terminologies is available.",
    "experimental": false,
    "title": "Parameter Codes eCRF",
    "name": "ParameterCodeseCRF",
    "publisher": "Charité",
    "status": "active",
    "version": "1.0",
    "url": "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/ecrf-parameter-codes",
    "resourceType": "CodeSystem"
}